DE BRAUD, FILIPPO GUGLIELMO MARIA

DE BRAUD, FILIPPO GUGLIELMO MARIA  

Dipartimento di Oncologia ed Emato-Oncologia  

Mostra records
Risultati 1 - 20 di 575 (tempo di esecuzione: 0.001 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
"Burned out" phenomenon of the testis in retroperitoneal seminoma 2006 G. CuriglianoO. De CobelliM. RescignoF. De Braud + Article (author) -
18F-FLT PET/CT as an imaging tool for early prediction of pathological response in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy : a pilot study 2015 B. PadovanoF. de Braud + Article (author) -
5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer 2018 G. PelosiL. SpaggiariF. de Braud + Article (author) -
5-Fluorouracil as protracted continuous intravenous infusion can be added to full-dose docetaxel (Taxotere)-cisplatin in advanced gastric carcinoma: a phase I-II trial 2004 de Braud F + Article (author) -
A 15-min premedication for 1-h paclitaxel infusion: optimizing patients' care 2007 de Braud F + Article (author) -
A catalyst for change: The european cancer patient's bill of rights 2014 F. de BraudC. La Vecchia + Article (author) -
A classification prognostic score to predict OS in stage IV well-differentiated neuroendocrine tumors 2018 Pusceddu S.Barretta F.Botta L.De Braud F.Mazzaferro V.Massironi S. + Article (author) -
A combination of extracellular matrix- and interferon-associated signatures identifies high-grade breast cancers with poor prognosis 2021 De Braud F. + Article (author) -
A critical appraisal of the adjuvant chemotherapy guidelines for patients with completely resected T3N0 non-small-cell lung cancer 2010 S. RaimondiG. PelosiL. SpaggiariF. De Braud + Article (author) -
A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic Melanoma 2011 de Braud F + Article (author) -
A first in human phase I study of the proteasome inhibitor CEP-18770 in patients with advanced solid tumours and multiple myeloma 2013 F. De Braud + Article (author) -
A FOLFIRI-induced complete tumor response in a patient with FOLFOX-refractory metastatic duodenal adenocarcinoma 2010 G. PelosiF. De Braud + Article (author) -
A melanoma subtype with intrinsic resistance to BRAF inhibition identified by receptor tyrosine kinases gene-driven classification 2015 F. De Braud + Article (author) -
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer 2015 F. PietrantonioP. BiondaniNIGER, MONICAGHIDINI, MICHELEBOZZARELLI, SILVIAF. De Braud + Article (author) -
A Phase I dose-escalation study with weekly taxol and gemcitabine in patients with advanced non small cell lung cancer 1998 de Braud F + Article (author) -
A Phase I Study of the Anti-Activin Receptor-Like Kinase 1 (ALK-1) Monoclonal Antibody PF-03446962 in Patients with Advanced Solid Tumors 2016 F.G. De Braud + Article (author) -
A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor,brivanib, in patients with advanced or metastatic solid tumors 2011 de Braud F + Article (author) -
A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumors 2015 F. de Braud + Article (author) -
A proper schedule of weekly paclitaxel and gemcitabine combination is highly active and very well tolerated in NSCLC patients 2006 G. CuriglianoL. SpaggiariF. de Braud + Article (author) -
A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients 2001 F. De BraudARNALDI, PATRIZIAM. BellomiB. Andreoni + Article (author) -